Central Nervous System (CNS) Therapeutics Market is
Projected to Grow Massively in Near Future by 2030

Central Nervous System (CNS) Therapeutics
Market Growth
Trend & Forecast with latest research study released by Delvens evaluating
the market risk side analysis, highlighting opportunities, and leveraging
strategic and tactical decision-making support. The report provides information
on market trends and development, growth drivers, technologies, and the
changing investment structure of the Global market, the Central Nervous System
(CNS) Therapeutics market size was estimated at USD 104.70 billion in 2023 and
is projected to reach USD 159.84 billion in 2030 at a CAGR of 6.23% during the
forecast period to 2030.

Get Free Sample
Report: https://www.delvens.com/get-free-sample/central-nervous-system-therapeutics-market

Central Nervous System (CNS) therapeutics are drugs that are
used to treat diseases of the brain and spinal cord. They are a broad class of
drugs that include many different types, each with its own specific mechanism
of action. The CNS includes the brain and spinal cord and plays a crucial role
in controlling various bodily functions and behaviours. CNS therapeutics are
used to treat a wide range of neurological and psychiatric conditions.

North America to
Dominate the Market

·       
North America is estimated to account for the
largest market share during the forecast period. The increased usage of
technology in the healthcare sector in the United States, along with the
increasing product launches, owing to the rising burden of the central nervous
system disease, and the rising level of research and development are driving
the growth of the market.

·       
Moreover, the rising burden of neurodegenerative
diseases such as Alzheimer’s within the region is expected to contribute to the
market growth during the forecast period.

The Prominent Players
in the Central Nervous System (CNS) Therapeutics
Market:

·       
Biogen

·       
Otsuka Pharmaceutical Co. Ltd

·       
Eli Lilly and Company

·       
Merck KGaA

·       
AstraZeneca

·       
Takeda Pharmaceutical Company Limited

·       
Novartis AG

·       
Teva Pharmaceutical Industries Ltd

·       
Johnson & Johnson Private Limited

·       
AbbVie Inc.

·       
BIAL Group

·       
Bristol-Myers Squibb

·       
Allergan Plc

·       
Alkermes Plc and More

Key Findings

·       
The market is bifurcated based on disease into
neurovascular diseases, trauma, mental health, degenerative disease, infectious
diseases, cancer, and others. The degenerative disease is expected to dominate
the market in this segment. This growth can be attributed to the increasing
prevalence of Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

·       
Based on drug class, the market is segmented
into analgesics, antidepressants, anaesthetics, anti-Parkinson drugs,
anti-epileptics, and other drug classes. The antidepressants segment led the
CNS therapeutics market in this segment and is expected to dominate the market
during the forecast period due to increasing prevalence of depression and the
rising demand for effective treatments.

·       
Based on distribution channel, the market can be
segmented into hospital-based pharmacies, retail-based pharmacies and online
pharmacies. The hospital-based pharmacies dominated the market in this segment
due to rapid increase in prevalence of CNS diseases in geriatric population,
technological advancements and lifestyle changes.

·       
By age group, the market is segmented into
paediatric, adult and geriatric. The geriatric population dominated the market
in this segment and is expected to dominate the market during the forecast
period.

·       
The market is also divided into various regions
such as North America, Europe, Asia-Pacific, South America, and Middle East and
Africa. North America is estimated to account for the largest market share
during the forecast period.

Access Full Report: https://www.delvens.com/report/central-nervous-system-therapeutics-market

In addition to the
market data for the Central Nervous System (CNS) Therapeutics Market, Delvens
offers client-centric reports customized according to the company’s specific
demand and requirements.

More Related Reports:

Advanced Wound Care market

Immunohistochemistry (IHC) Market

Biostimulants Market

About Us:

Delvens is a strategic advisory and consulting company
headquartered in New Delhi, India. The company holds expertise in providing
syndicated research reports, customized research reports and consulting
services. Delvens qualitative and quantitative data is highly utilized by each
level from niche to major markets, serving more than 1K prominent companies by
assuring to provide the information on country, regional and global business
environment. We have a database for more than 45 industries in more than 115+
major countries globally.

Delvens database assists the clients by providing in-depth
information in crucial business decisions. Delvens offers significant facts and
figures across various industries namely Healthcare, IT & Telecom,
Chemicals & Materials, Semiconductor & Electronics, Energy,
Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our
company provides an exhaustive and comprehensive understanding of the business
environment.

Contact us:

Unit No. 01, 3rd Floor, Plot No. 56, Block B

Sector 2 Noida, Near Noida Sector 15 Metro Station 201301,
IN

+44 20 3290 6466

+0120- 4903958

sales@delvens.com